These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19142715)
1. The phosphorylation status of merlin in sporadic vestibular Schwannomas. Wang Z; Lu Y; Tang J; Wang H; Wu H Mol Cell Biochem; 2009 Apr; 324(1-2):201-6. PubMed ID: 19142715 [TBL] [Abstract][Full Text] [Related]
2. Involvement of p21 (waf1) in merlin deficient sporadic vestibular schwannomas. Wu H; Chen Y; Wang ZY; Li W; Li JQ; Zhang L; Lu YJ Neuroscience; 2010 Sep; 170(1):149-55. PubMed ID: 20600642 [TBL] [Abstract][Full Text] [Related]
3. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas. Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805 [TBL] [Abstract][Full Text] [Related]
4. [Expression of S518 phosphorylated Merlin and its interaction with CD44 in vestibular schwannoma]. Cai LH; Wu H; Lü JR; Wang ZY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Dec; 43(12):910-4. PubMed ID: 19141242 [TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis and molecular pathology of vestibular schwannoma]. Brodhun M; Stahn V; Harder A HNO; 2017 May; 65(5):362-372. PubMed ID: 27421984 [TBL] [Abstract][Full Text] [Related]
6. [Research advances in molecular mechanisms underlying the different biological behaviors of vestibular schwannoma]. Wang ZY; Yang J; Wu H Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):473-5. PubMed ID: 27345892 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China. Bian LG; Tirakotai W; Sun QF; Zhao WG; Shen JK; Luo QZ J Neurooncol; 2005 Jul; 73(3):253-60. PubMed ID: 15980976 [TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation. Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516 [TBL] [Abstract][Full Text] [Related]
9. Compensative shuttling of merlin to phosphorylation on serine 518 in vestibular schwannoma. Lü J; Zou J; Wu H; Cai L Laryngoscope; 2008 Jan; 118(1):169-74. PubMed ID: 17989580 [TBL] [Abstract][Full Text] [Related]
10. Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells. Petrilli AM; Garcia J; Bott M; Klingeman Plati S; Dinh CT; Bracho OR; Yan D; Zou B; Mittal R; Telischi FF; Liu XZ; Chang LS; Welling DB; Copik AJ; Fernández-Valle C Oncotarget; 2017 May; 8(19):31666-31681. PubMed ID: 28427224 [TBL] [Abstract][Full Text] [Related]
11. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury. Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084 [TBL] [Abstract][Full Text] [Related]
12. The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals. Chen H; Zhang X; Zhang Z; Yang T; Wang Z; Wu H Mol Cell Biochem; 2014 Jul; 392(1-2):145-52. PubMed ID: 24619252 [TBL] [Abstract][Full Text] [Related]
13. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin. Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658 [TBL] [Abstract][Full Text] [Related]
14. The molecular biology and novel treatments of vestibular schwannomas. Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin. Kim H; Lim JY; Kim YH; Kim H; Park SH; Lee KH; Han H; Jeun SS; Lee JH; Rha HK Mol Cells; 2002 Aug; 14(1):108-14. PubMed ID: 12243339 [TBL] [Abstract][Full Text] [Related]
16. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731 [TBL] [Abstract][Full Text] [Related]
18. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759 [TBL] [Abstract][Full Text] [Related]
19. [Expression and localization of merlin in vestibular schwannoma]. Lü JR; Zou J; Wu H Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jul; 41(7):501-5. PubMed ID: 17007372 [TBL] [Abstract][Full Text] [Related]
20. Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns. Chen H; Xue L; Wang H; Wang Z; Wu H Sci Rep; 2017 Jul; 7(1):5470. PubMed ID: 28710469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]